Search
-
Looking at the impact of COVID-19 on the economy & the MedTech industry in China
Ipsos’ Medical Devices & Diagnostics (MD&D) team in China has created a series of reports, with aim to shed some light on the questions that have arisen regarding the impact of COVID-19 on the domestic economy, healthcare industry and specifically, the medical devices sector in China.
-
Ipsos Update - June 2020
This month’s round-up of research and analysis from Ipsos around the world includes the latest insights on the impacts of coronavirus and how we can plan for the future, customer experience – including the emerging health and safety agenda, attitudes to work, the second world war, and public opinion from New Zealand and Australia.
-
Preparing for the future of the operating room: Robotics
Imagine a future where surgical robots have become small and affordable enough to be found even in non-specialized hospitals and outpatient clinics outside of a major metropolis...
-
Ways medical device companies maintain connections during Covid-19
Read our five recommendations for medical device manufacturers to maintain connections and foster effective engagement with customers during Covid-19.
-
Leading pharmaceutical brands demonstrating leadership
As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.
-
Assessing the risk profile of recently launched drugs
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.
-
Signals #4: Understanding the coronavirus crisis
This fourth edition sees us bring together our latest research on coronavirus and draws on our surveys, social media monitoring and the analysis of our teams around the world.
-
Multi-source healthcare data
The world of pharma business insight is likely to change as it embraces a multi-data source reality.
-
The world after
The Covid-19 epidemic has magnified the extreme fragility of the French healthcare system, facing unequaled demand for care and ending up almost bled dry. Preserving its mission implies a real transformation.